Dengue NS1

Medical Analysis

Introduction to Dengue Virus and NS1 Antigen

Dengue virus (DENV) belongs to the family Flaviviridae, genus Flavivirus [8]. It is transmitted to humans by Aedes mosquitoes, mainly Aedes aegypti [8]. Dengue virus has 4 serotypes (DENV-1, DENV-2, DENV-3, and DENV-4) [8]. DENV infection is a major cause of disease in tropical and subtropical areas. Infection with any of the DENV serotypes may be asymptomatic in the majority of cases [8]. It may result in a wide spectrum of clinical symptoms, ranging from a mild flu-like syndrome (known as dengue fever [DF]) to the most severe forms of the disease, which are characterized by coagulopathy, increased vascular fragility, and permeability (dengue hemorrhagic fever [DHF]) [8]. The latter may progress to hypovolemic shock (dengue shock syndrome [DSS]) [8].

Clinical Symptoms and Disease Classification

It is characterized by the rapid onset of fever in combination with severe headache, retro-orbital pain, myalgia, arthralgia, gastrointestinal discomfort, and usually rash [7]. Minor hemorrhagic manifestations may occur in the form of petechiae, epistaxis, and gingival bleeding [7]. Leukopenia is a common finding, whereas thrombocytopenia may occasionally be observed in DF [7]. WHO classifies DHF in four grades (I to IV) [7]. DHF grades I and II represent relatively mild cases without shock [7]. Whereas grade III and IV cases are more severe and accompanied by shock [7].

Dengue Serology and NS1 Antigen Kinetics

Dengue Serology involves tracking Viraemia, -IgM, Antibody/antigen level, IgG, IgA, and NS1 across a time frame of 2 to 14 days [8].

Phases of NS1 antigen kinetics in Dengue fever

Dengue NS1 Testing Parameters

• Indication: Early stages of suspected Dengue fever [6].

• Sample: Whole blood or serum [3].

• Method: Immunochromatography and ELISA formats [2, 3].

Rapid Test Principle and Procedure

Principle of Rapid Testing

The principle of agglutination of antibodies/ antisera with respective antigen in immunochromatography format along with use of nano gold particles as agglutination revealing agent [3]. As the test sample flows through the membrane assembly of the device, the highly specific Agglutinating sera for dengue NS 1 – colloidal gold conjugate complexes with dengue NS 1 antigen present in the sample and travels on the membrane due to capillary action [3]. The complex moves further on the membrane to the test region (T) where it is immobilized by another specific Agglutinating sera for dengue NS 1 coated on the membrane leading to the formation of a pink-purple band [3].

Test Procedure Steps

1. Open foil pouch by tearing along the “notch” and remove NS 1 antigen testing device, just prior to the testing [3].

2. Label the device with specimen identity and place it on a flat horizontal surface and perform the test [3].

3. Holding the sample applicator vertically, carefully dispense exactly 3 drops (75 µl) of the serum/plasma specimen into the specimen port (S) [3].

4. Alternatively, using a 75 µl precision micropipette, carefully dispense exactly 75 µl of the serum/ plasma specimen into the specimen port (S) [3].

5. Immediately start the stopwatch and read the result at the end of 15 minutes [3].

Result Interpretation

• Negative Result: Only one pink / purple colored band appears at the Control Region (C). This indicates absence of dengue NS 1 antigen in the specimen [3].

• Positive Result: Two pink / purple colored bands appear at the Control Region (C) and Test Region (T). This indicates that the specimen contains detectable level of Dengue NS 1 antigen [3].

• Invalid Result: The test result is invalid if no bands appear on the device [3]. The test should also be considered invalid if only the test band appears and no control band appears [3]. Verify the test procedure and repeat the test with a new device [3].

ELISA Principle and Laboratory Procedure

It is a solid phase enzyme linked immunosorbent assay (ELISA) based on the “Direct Sandwich” principle [4]. The microwells are coated with Anti-dengue NSlantibodies with high reactivity for Dengue NS1 Ag [4]. The samples are added in the wells followed by addition of enzyme conjugate (monoclonal anti-dengue NS1 antibodies linked to Horseradish Peroxidase (HRPO)) [4]. A sandwich complex is formed in the well wherein dengue NS1 (from serum sample) is “trapped” or “sandwiched” between the antibody and antibody HRPO conjugate [4]. Unbound conjugate is then washed off with wash buffer [4]. Upon addition of the substrate buffer and chromogen, a blue colour develops [4]. To limit the enzyme-substrate reaction, stop solution is added and a yellow colour develops which is finally read at 450nm spectrophotometrically [4].

ELISA Calculation and Interpretation

Dengue NS1 antigen units calculated as follows, Dengue NS1 antigen units = Sample OD X 10 / Cut off value [4].

Dengue NS1 Test Result Overview

Clinical Significance and Limitations

Clinical Significance

• Early diagnosis Useful During the Viremic Phase: NS1 antigen can be detected from the first day of fever, even before antibodies (lgM/lgG) appear, enabling early confirmation of dengue infection [4]. Detects NS1 antigen circulating during the viremic (acute) phase, confirming active infection [4].

• Supports Outbreak Surveillance: Facilitates timely identification of dengue cases, crucial for outbreak monitoring and public health response [2].

• Indicator of Viral Load: High NS1 levels may correlate with higher viral loads, potentially linked to disease severity [2, 8].

• Complement to Antibody Tests: When combined with IgM and IgG serology, NS1 testing improves overall diagnostic accuracy and helps identify both early and late infections [7, 8].

Limitations of Dengue NS1 Testing

• Reduced sensitivity in secondary infections: NS1 levels are often lower during secondary dengue infections due to pre-existing antibodies that clear the antigen faster [3, 8].

• Limited detection window: The NS1 antigen is mainly detectable during the early phase (first 1-5 days) of infection; after that, levels drop significantly [3, 4].

• Cross-reactivity: Possible cross-reactivity with other flaviviruses (e.g., Zika, Japanese Encephalitis, Yellow Fever) can lead to false positives [6].

• False negatives: Low antigenemia, late sample collection, or poor sample handling can cause false-negative results [3, 6].

• Quality variations among test kits: Sensitivity and specificity can vary depending on the brand and assay type (ELISA vs. rapid test) [2, 3].

• Limited utility in co-infections: NS1 detection may be affected when dengue co-occurs with other viral infections, reducing test accuracy [6].

For Non-Medicos

Understanding Dengue and What the NS1 Test Means

Dengue is a viral infection spread primarily by Aedes mosquitoes [8]. It causes sudden high fever, severe headaches, pain behind the eyes, muscle and joint pain, and rashes [7]. While many cases are mild, some can develop into severe bleeding or shock conditions that require immediate medical supervision [7, 8].

How the Dengue NS1 Test Works for Patients

The Dengue NS1 test looks for a specific viral protein (antigen) that circulates in the blood during the very early days of an active infection [4]. You can use whole blood or serum samples for this test [3]. Healthcare providers use rapid strip tests or laboratory ELISA assays to detect these proteins within 15 minutes or through standard laboratory processing [3, 4].

Interpreting Your Results and Next Steps

• Positive Result: Confirms an active, acute dengue infection, usually detectable within 1 to 9 days after symptoms start [3, 4]. A late positive result can sometimes point toward a higher risk of severe disease progression [4].

• Negative Result: Means no NS1 antigen was found, but it does not completely rule out dengue because testing too early or too late can cause missed detection [3, 4]. A follow-up antibody test like IgM is often recommended by doctors if symptoms persist [7, 8].

References:

1. Sa-ngamuang, C., Haddawy, P., Luvira, V., Piyaphanee, W., Iamsirithaworn, S., & Lawpoolsri, S. (2018). Accuracy of dengue clinical diagnosis with and without NS1 antigen rapid test: Comparison between human and Bayesian network model decision. PLOS Neglected Tropical Diseases, 12(6), e0006573. https://doi.org/10.1371/journal.pntd.0006573

2. Shan, X., Wang, X., Yuan, Q., Zheng, Y., Zhang, H., Wu, Y., & Yang, J. (2015). Evaluation of the diagnostic accuracy of nonstructural protein 1 Ag-based tests for dengue virus in Asian population: a meta-analysis. BMC Infectious Diseases, 15, 392. https://doi.org/10.1186/s12879-015-1088-4

3. Liu, L. T. (2025). Performance comparison of two dengue NS1 rapid diagnostic tests against RT-PCR: Sensitivity and specificity across infections and timeframes. Journal of Infection and Public Health, 18(3), 102919. https://doi.org/10.1016/j.jiph.2025.102919

4. Anand, A. M., & Kaliappan, S. (2016). Evaluation of NS1 antigen detection for early diagnosis of dengue in a tertiary hospital in southern India. Journal of Clinical and Diagnostic Research, 10(4), DC01–DC04. https://doi.org/10.7860/jcdr/2016/15758.7562

5. Nisalak, A. (2015). Laboratory diagnosis of dengue virus infections. Southeast Asian Journal of Tropical Medicine and Public Health, 46(1), 55–76.

6. Mishra, B., Gupta, P. K., Dhiman, V., Pujhari, S. K., Sharma, M., & Ratho, R. K. (2014). Clinical applicability of various dengue diagnostic tests in resource-limited endemic settings. Journal of Global Infectious Diseases, 6(3), 109–115. https://doi.org/10.4103/0974-777X.138504

7. Chan, H. B. Y., How, C. H., & Ng, C. W. (2017). Definitive tests for dengue fever: when and which should I use? Singapore Medical Journal, 58(12), 632–635. https://doi.org/10.11622/smedj.2017100

8. Muller, D. A., Depelsenaire, A. C. I., & Young, P. R. (2017). Clinical and laboratory diagnosis of dengue virus infection. The Journal of Infectious Diseases, 215(Suppl 2), S89–S95. https://doi.org/10.1093/infdis/jiw649

9. de Paula, S. O., Dutra, N. R., de Paula, M. B., de Oliveira, M. D., & de Oliveira, L. L. (2009). The laboratorial diagnosis of dengue: Applications and implications. Journal of Global Infectious Diseases, 1(1), 38–44. https://doi.org/10.4103/0974-777X.52980

FAQ’s:

1. What is dengue virus?
Dengue virus belongs to Flaviviridae and is spread by Aedes mosquitoes.

2. How many dengue serotypes exist?
There are four distinct serotypes: DENV-1, DENV-2, DENV-3, and DENV-4.

3. What are main clinical symptoms?
Rapid onset fever, severe headache, retro-orbital pain, myalgia, arthralgia, and rash.

4. When does NS1 peak?
NS1 antigen levels peak in blood during the early febrile phase (days 0-3).

5. What sample is required?
Whole blood or serum samples are required for testing.

6. How does rapid testing work?
Immunochromatography with nano gold particles reveals antigen-antibody agglutination reactions.

7. What does positive NS1 mean?
It confirms acute dengue infection within 1 to 9 days after symptoms.

8. Why is ELISA used?
It uses direct sandwich principles with enzyme conjugates for quantitative optical readings.

9. Can NS1 yield false negatives?
Yes, due to low antigenemia, late collection, or pre-existing antibodies.

10. Does cross-reactivity occur?
Yes, with other flaviviruses like Zika, Japanese Encephalitis, and Yellow Fever.

Related Tests

• Platelet Count Test
• Liver Function Test